Baby food composition comprising viable propionic acid-producing bacteria

11179,427

16/251351

January 18, 2019

The present invention relates to compositions, particularly baby food compositions, including living propionic acid-producing bacteria, preferably lactate-utilizing propionic acid-producing bacteria, their manufacture and use in the treatment of digestive diseases, particularly for treatment of infantile colic.

ETH ZURICH (Zürich, CH); UNIVERSITÄT ZÜRICH (Zürich, CH)

ETH ZURICH (Zürich, CH)

1. A method of treating infantile colic in a subject in need thereof, the method comprising administering to the subject an infant nutritional product comprising: (a) viable lactic acid-producing bacteria from one or more live bacteria strains; (b) viable, lactate utilizing, propionic acid producing bacteria from one or more live Cutibacteria strains; and (c) optionally prebiotics.

2. The method according to claim 1 , wherein said viable, lactate utilizing, propionic acid producing bacteria are C. avidum.

3. The method according to claim 1 , wherein said viable lactic acid-producing bacteria (a) are selected from the group consisting of Bifidobacterium spp., Lactobacillus spp., Lactococcus spp., Streptococcus spp., Enterococcus spp., Leuconostoc spp., and Weissella spp.

4. The method according to claim 1 , wherein the infant nutritional product further comprises additives.

5. The method according to claim 1 , wherein the infant nutritional product includes probiotics, and the prebiotics are selected from the group consisting of fructooligosaccharides (FOS) and galactooligosaccharides (GOS).

6. The method according to claim 1 , wherein the infant nutritional product further comprises baby milk or baby milk powder.

7. The method according to claim 1 , wherein the amount of said viable bacteria is in the range of 10 2 to 10 12 CFU per gram or per mL of product.

8. The method according to claim 1 , wherein the infant nutritional product is designed to be administered to infants or young children starting from the age of 6 months and provides complete nutrition to the infant or child.

9. The method according to claim 1 , comprising administering a baby formula comprising the infant nutritional product.

10. The method according to claim 9 , wherein the baby formula is in the form of a baby milk.

11. The method according to claim 9 , wherein the baby formula is in the form of a kit of parts, wherein a first part comprises the infant nutritional product and the second part comprises a baby formula free of viable bacteria.

12. The method according to claim 11 , wherein the second part comprises baby milk.

5599795 February 1997 McCann et al.
6080401 June 2000 Reddy et al.
6262019 July 2001 Keller et al.
6645530 November 2003 Borody
RE39705 June 2007 Keller et al.
7374924 May 2008 Connolly et al.
RE40849 July 2009 Keller et al.
7629155 December 2009 Sato et al.
7834061 November 2010 Sato et al.
8025911 September 2011 Uchida et al.
8110607 February 2012 Sato et al.
8241684 August 2012 Uchida et al.
8309073 November 2012 Mayra-Makinen et al.
8460648 June 2013 Borody
8604005 December 2013 Kajander et al.
8691213 April 2014 Langford et al.
8758842 June 2014 Furuichi et al.
9040036 May 2015 Borody
9050358 June 2015 Borody
9057112 June 2015 Connolly et al.
9255246 February 2016 Scatizzi
9320763 April 2016 Borody
2003/0138476 July 2003 Van Leeuwen et al.
2004/0062757 April 2004 Finegold
2004/0062758 April 2004 Mayra-Makinen et al.
2004/0005304 June 2004 Brudnak
2004/0170617 September 2004 Finegold
2004/0185032 September 2004 Burrell
2005/0180963 August 2005 Adams et al.
2007/0258953 November 2007 Duncan et al.
2007/0298013 December 2007 Altman
2008/0069861 March 2008 Brown et al.
2008/0311097 December 2008 Israelsen
2010/0028449 February 2010 Prakash et al.
2010/0166721 July 2010 Masri
2010/0284979 November 2010 O'Mahoney et al.
2011/0052538 March 2011 Brown et al.
2011/0110905 May 2011 Ritchie
2011/0165127 July 2011 Masri
2011/0189132 August 2011 Garner et al.
2011/0223137 September 2011 Darmaun et al.
2012/0034198 February 2012 Garner et al.
2012/0121562 May 2012 Bergonzelli Degonda et al.
2012/0121564 May 2012 Connolly et al.
2012/0128726 May 2012 Mercenier et al.
2012/0134973 May 2012 Kekkonen
2012/0171166 July 2012 Chow et al.
2012/0230956 September 2012 McLean et al.
2012/0269789 October 2012 Mercenier et al.
2013/0189236 July 2013 Ware
2013/0224166 August 2013 Mercenier et al.
2013/0273015 October 2013 Klassen et al.
2013/0280239 October 2013 Klassen et al.
2013/0330307 December 2013 Millan
2013/0330308 December 2013 Millan et al.
2014/0037603 February 2014 Bolster et al.
2014/0093479 April 2014 Mogna et al.
2014/0112985 April 2014 Bochenek et al.
2014/0193542 July 2014 Langford et al.
2014/0234279 August 2014 Millan
2015/0174080 June 2015 Schiffrin et al.
2015/0181916 July 2015 Klassen et al.
2015/0290261 October 2015 Chichlowski et al.
2015/0352162 December 2015 Chassard et al.
0 433 299 May 1998
1 308 506 May 2003
1 374 878 January 2004
0 888 118 November 2004
1 987 835 November 2008
1 513 541 January 2009
1 782 818 September 2009
1 869 161 January 2010
2 110 133 August 2011
1 531 841 November 2011
2 169 050 April 2014
2 585 085 May 2014
2 164 349 September 2014
2 040 722 November 2015
2004000340 December 2003
2004085628 October 2004
2005060937 July 2005
2011020780 February 2011
2012059502 May 2012
2012142605 October 2012
WO-2014110685 July 2014
2015017625 February 2015
2015018883 February 2015
2015065194 May 2015
2015112083 July 2015
2015120098 August 2015
2015177246 November 2015

International Search Report for corresponding International Application No. PCT/CH2014/000006 dated Mar. 27, 2014. cited by applicant
Written Opinion for corresponding International Application No. PCT/CH2014/000006 dated Mar. 27, 2014. cited by applicant
O'Callaghan et al., “Infant Formulae—New Developments”, Encyclopedia of Dairy Sciences, 2012, pp. 1384-1392 (cited in specification on p. 1). cited by applicant
Moat et al., “Fermentation Pathways”,Microbial Physiology, Chapter 11, 2002, pp. 412-433 (cited in specification on p. 4). cited by applicant
Hosseini et al., “Propionate as a health-promoting microbial metabolite in the human gut”, Nutrition Reviews, vol. 69 (5), 2011, pp. 245-258 (cited in specification on p. 8). cited by applicant
Arslanoglu et al., “Early Dietary Intervention with a Mixture of Prebiotic Oligosaccharides Reduces the Incidence of Allergic Manifestations and Infections during the First Two Years of Life”, The Journal of Nutrition, Nutrition and Disease, 2008, pp. 1091-1095 (cited in specification on p. 9). cited by applicant
Grattepanche et al., “Production of viable probiotic cells”, Microbial production of food ingredients, enzymes and nutraceuticals, 2013, pp. 321-352 (cited in specification on p. 15). cited by applicant
Walstra et al., “Milk Powder”, Dairy Science and Technology, Chapter 20, 2006, pp. 513-535 (cited in specification on p. 15). cited by applicant
Schuck, “Dehydrated Dairy Products / Milk Powder: Types and Manufacture”, Encyclopedia of Dairy Sciences, 2011, pp. 108-116 (cited in specification on p. 15). cited by applicant
Jay et al., Modern Food Microbiology, Seventh Edition, 2005, 45 pages (cited in specification on p. 7). cited by applicant
Braegger et al., “Supplementation of Infant Formula With Probiotics and/or Prebiotics: A Systematic Review and Comment by the ESPGHAN Committee on Nutrition”, JPGN, vol. 52, No. 2, Feb. 2011. cited by applicant
Parker et al., “Interactions of Lactobacilus and Propionibacterium in Mixed Culture”, Journal of Food Protection, vol. 45, No. 4, Mar. 1982, pp. 326-330. cited by applicant
Pham et al., “Lactate-utilizing community is associated with gut microbiota dysbiosis in colicky infants”, Nature, Scientific Reports, 7:11176, Sep. 2017, pp. 1-13. cited by applicant
Rocha Martin et al., “Colonization of Cutibacterium avidum during infant gut microbiota establishment”, FEMS Microbiology Ecology, No. 95, No. 1,2019, pp. 1-14. cited by applicant

edspgr.11179427